Reduced bone marrow stem cell pool and progenitor mobilisation in multiple myeloma after melphalan treatment (Q28378324)

Crossref

https://api.crossref.org/works/10.1007%2FBF02785870

Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts

21 January 2018

1 reference

12 December 2020

Gel-loading dyes compatible with PCR

1 reference

12 December 2020

Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood.

1 reference

12 December 2020

Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma

1 reference

12 December 2020

Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor

1 reference

12 December 2020

Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients.

1 reference

12 December 2020

Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor.

1 reference

12 December 2020

Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both

1 reference

12 December 2020

Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy

1 reference

12 December 2020

Nordic flow cytometry standards for CD34+ cell enumeration in blood and leukapheresis products: report from the second Nordic Workshop. Nordic Stem Cell Laboratory Group (NSCL-G)

1 reference

12 December 2020

Chemotherapy of multiple myeloma

1 reference

12 December 2020

Quantitative analysis of CD34+ stem cells using RT-PCR on whole cells.

1 reference

12 December 2020

Structure of the gene encoding CD34, a human hematopoietic stem cell antigen

1 reference

12 December 2020

Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors

1 reference

12 December 2020

Identification and characterisation of malignant cells using RT-PCR on single flow-sorted cells

1 reference

12 December 2020

Comparative study of peripheral blood progenitor cell collection in patients with multiple myeloma after single-dose cyclophosphamide combined with rhGM-CSF or rhG-CSF.

1 reference

12 December 2020

A functional comparison of CD34 + CD38- cells in cord blood and bone marrow

1 reference

12 December 2020

Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials

1 reference

12 December 2020

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

12 December 2020

Peripheral blood progenitor cell collections in multiple myeloma: predictors and management of inadequate collections.

1 reference

12 December 2020

Is aggressive chemotherapy more effective in the treatment of plasma cell myeloma?

1 reference

12 December 2020

Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma

1 reference

12 December 2020

Improved priming for mobilization of and optimal timing for harvest of peripheral blood stem cells

1 reference

12 December 2020

Flow cytometric characterization of CD34+ hematopoietic progenitor cells in mobilized peripheral blood and bone marrow of cancer patients.

1 reference

12 December 2020